A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-kidney transplant (PRI-VENT FSGS): protocol and study design

  • Michelle N. Rheault
  • , Sandra Amaral
  • , Margret Bock
  • , Eileen Tsai Chambers
  • , Blanche Chavers
  • , Mireile El Ters
  • , Rouba Garro
  • , Rasheed Gbadegesin
  • , Amit Govil
  • , Lyndsay Harshman
  • , Hatem Amer
  • , David K. Hooper
  • , Ajay K. Israni
  • , Samy Riad
  • , Junichiro Sageshima
  • , Ron Shapiro
  • , Michael Seifert
  • , Jodi Smith
  • , Randall Sung
  • , Christie P. Thomas
    • Qi Wang, Priya S. Verghese

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-kidney transplant (PRI-VENT FSGS): protocol and study design'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science